Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 059, 50870-50876 [2023-16418]
Download as PDF
50870
Federal Register / Vol. 88, No. 147 / Wednesday, August 2, 2023 / Notices
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the Proposed Extension without Change
and the information collection
requirements related to the National
Survey of Older Americans Act
Participants.
Comments on the collection of
information must be submitted
electronically by 11:59 p.m. (EST) or
postmarked by October 2, 2023.
ADDRESSES: Submit electronic
comments on the collection of
information to Kristen.Robinson@
acl.hhs.gov. Submit written comments
on the collection of information to
Administration for Community Living,
Washington, DC 20201, Attention:
Kristen Robinson.
FOR FURTHER INFORMATION CONTACT:
Kristen Robinson, Administration for
Community Living, Washington, DC
20201, by email at Kristen.Robinson@
acl.hhs.gov, or by telephone at 202–
795–7428.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
DATES:
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, ACL is publishing a notice
of the proposed collection of
information set forth in this document.
With respect to the following collection
of information, ACL invites comments
on our burden estimates or any other
aspect of this collection of information,
including:
(1) whether the proposed collection of
information is necessary for the proper
performance of ACL’s functions,
including whether the information will
have practical utility;
(2) the accuracy of ACL’s estimate of
the burden of the proposed collection of
information, including the validity of
the methodology and assumptions used
to determine burden estimates;
(3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and
(4) ways to minimize the burden of
the collection of information on
respondents, including using automated
collection techniques when appropriate,
and other forms of information
technology. The National Survey of
Older Americans Act (OAA)
Participants information collection
Number of
respondents
Respondent/data collection activity
includes consumer assessment surveys
for the Congregate and Home-delivered
meal nutrition programs; Case
Management, Homemaker, and
Transportation Services; and the
National Family Caregiver Support
Program. This survey builds on earlier
national pilot studies and surveys, as
well as performance measurement tools
developed by ACL grantees in the
Performance Outcomes Measures
Project (POMP). Changes identified as a
result of these initiatives were
incorporated into the last data collection
package that was approved by OMB and
are included in this proposed extension
of a currently approved collection.
This information will be used by ACL
to track performance outcome measures;
support budget requests; comply with
the GPRA Modernization Act of 2010
(GPRMA) reporting requirements;
provide national benchmark
information; and inform program
development and management
initiatives.
Copies of the survey instruments and
data from previous National Surveys of
OAA Participants can be found and
queried using the Aging, Independence,
and Disability (AGID) Program Data
Portal at https://agid.acl.gov/. The
proposed data collection tools may be
found on the ACL website at https://
www.acl.gov/about-acl/public-input.
Estimated Program Burden: ACL
estimates the annual burden associated
with this collection of information as
follows:
Responses
per
respondent
Hours per
response
Annual
burden
hours
Area Agency on Aging: Respondent selection process ..................................
Service recipients (i.e., Congregate and Home-Delivered Meal nutrition programs, Case Management, Homemaker, Transportation services) + Rotating Module ................................................................................................
National Family Caregiver Support Program clients + Rotating Module ........
300
1
4.0
1,200
4,000
2,000
1
1
0.75
0.75
3,000
1,500
Total ..........................................................................................................
6,300
1
* 0.90
5,700
* (weighted mean).
Dated: July 28, 2023.
Alison Barkoff,
Acting Administrator and Assistant Secretary
for Aging.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–16419 Filed 8–1–23; 8:45 am]
[Docket No. FDA–2004–N–0451]
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE 4154–01–P
Food and Drug Administration
Food and Drug Administration
Modernization Act of 1997:
Modifications to the List of Recognized
Standards, Recognition List Number:
059
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
VerDate Sep<11>2014
19:49 Aug 01, 2023
Jkt 259001
PO 00000
Notice.
Frm 00038
Fmt 4703
Sfmt 4703
The Food and Drug
Administration (FDA or Agency) is
announcing a publication containing
modifications the Agency is making to
the list of standards FDA recognizes for
use in premarket reviews (FDA
Recognized Consensus Standards). This
publication, entitled ‘‘Modifications to
the List of Recognized Standards,
Recognition List Number: 059’’
(Recognition List Number: 059), will
assist manufacturers who elect to
declare conformity with consensus
standards to meet certain requirements
for medical devices.
SUMMARY:
E:\FR\FM\02AUN1.SGM
02AUN1
Federal Register / Vol. 88, No. 147 / Wednesday, August 2, 2023 / Notices
Submit either electronic or
written comments on the notice at any
time. These modifications to the list of
recognized standards are applicable
August 2, 2023.
ADDRESSES: You may submit comments
on the current list of FDA Recognized
Consensus Standards at any time as
follows:
DATES:
ddrumheller on DSK120RN23PROD with NOTICES1
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2004–N–0451 for ‘‘Food and Drug
Administration Modernization Act of
1997: Modifications to the List of
Recognized Standards, Recognition List
Number: 059.’’ Received comments will
be placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
VerDate Sep<11>2014
19:49 Aug 01, 2023
Jkt 259001
a.m. and 4 p.m., Monday through
Friday, 240–402–7500. FDA will
consider any comments received in
determining whether to amend the
current listing of modifications to the
list of recognized standards, Recognition
List Number: 059.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
An electronic copy of Recognition List
Number: 059 is available on the internet
at https://www.fda.gov/MedicalDevices/
DeviceRegulationandGuidance/
Standards/ucm123792.htm. See section
IV for electronic access to the searchable
database for the current list of FDArecognized consensus standards,
including Recognition List Number: 059
modifications and other standardsrelated information. Submit written
requests for a single hard copy of the
document entitled ‘‘Modifications to the
List of Recognized Standards,
Recognition List Number: 059’’ to
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
50871
Jianchao Zeng, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5572, Silver Spring,
MD 20993, 301–796–6580. Send one
self-addressed adhesive label to assist
that office in processing your request, or
fax your request to 301–847–8144.
FOR FURTHER INFORMATION CONTACT:
Jianchao Zeng, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5572, Silver Spring,
MD 20993, 301–796–6580,
CDRHStandardsStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
Section 204 of the Food and Drug
Administration Modernization Act of
1997 (Pub. L. 105–115) amended section
514 of the Federal Food, Drug, and
Cosmetic Act (FD&C Act) (21 U.S.C.
360d). Amended section 514 of the
FD&C Act allows FDA to recognize
consensus standards developed by
international and national organizations
for use in satisfying portions of device
premarket review submissions or other
requirements.
In the Federal Register of September
14, 2018 (83 FR 46738), FDA announced
the availability of a guidance entitled
‘‘Appropriate Use of Voluntary
Consensus Standards in Premarket
Submissions for Medical Devices.’’ The
guidance describes how FDA has
implemented its standards recognition
program and is available at https://
www.fda.gov/regulatory-information/
search-fda-guidance-documents/
appropriate-use-voluntary-consensusstandards-premarket-submissionsmedical-devices. Modifications to the
initial list of recognized standards, as
published in the Federal Register, can
be accessed at https://www.fda.gov/
medical-devices/standards-andconformity-assessment-program/federalregister-documents.
These notices describe the addition,
withdrawal, and revision of certain
standards recognized by FDA. The
Agency maintains on its website HTML
and PDF versions of the list of FDA
Recognized Consensus Standards,
available at https://www.fda.gov/
medical-devices/standards-andconformity-assessment-program/federalregister-documents. Additional
information on the Agency’s Standards
and Conformity Assessment Program is
available at https://www.fda.gov/
medical-devices/device-advicecomprehensive-regulatory-assistance/
standards-and-conformity-assessmentprogram.
E:\FR\FM\02AUN1.SGM
02AUN1
50872
Federal Register / Vol. 88, No. 147 / Wednesday, August 2, 2023 / Notices
II. Modifications to the List of
Recognized Standards, Recognition List
Number: 059
FDA is announcing the addition,
withdrawal, correction, and revision of
certain consensus standards the Agency
is recognizing for use in premarket
submissions and other requirements for
devices. FDA is incorporating these
modifications to the list of FDA
Recognized Consensus Standards in the
Agency’s searchable database. FDA is
using the term ‘‘Recognition List
Number: 059’’ to identify the current
modifications.
In table 1, FDA describes the
following modifications: (1) the
withdrawal of standards and their
replacement by others, if applicable; (2)
the correction of errors made by FDA in
listing previously recognized standards;
and (3) the changes to the
supplementary information sheets of
recognized standards that describe
revisions to the applicability of the
standards.
In section III, FDA lists modifications
the Agency is making that involve new
entries and consensus standards added
as modifications to the list of recognized
standards under Recognition List
Number: 059.
TABLE 1—MODIFICATIONS TO THE LIST OF RECOGNIZED STANDARDS
Old
recognition
No.
Replacement
recognition
No.
Title of standard 1
Change
A. Anesthesiology
1–67 ...........
1–153
NFPA 99:2021 Health Care Facilities Code ................................................
1–78 ...........
1–154
1–132 .........
1–155
1–133 .........
1–156
1–142 .........
1–157
ASME PVHO–1–2019 Safety Standard for Pressure Vessels for Human
Occupancy.
ISO 10079–2 Fourth edition 2022–03 Medical suction equipment—Part 2:
Manually powered suction equipment.
ISO 10079–3 Fourth edition 2022–03 Medical suction equipment—Part 3:
Suction equipment powered from a vacuum or positive pressure gas
source.
ISO 10079–1 Fourth edition 2022–03 Medical suction equipment—Part 1:
Electrically powered suction equipment.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
Withdrawn and replaced with newer
version.
B. Biocompatibility
2–93 ...........
2–297
2–276 .........
2–298
2–289 .........
........................
2–296 .........
........................
ASTM F763–22 Standard Practice for Short-Term Intramuscular Screening of Implantable Medical Device Materials.
ISO 10993–18 Second edition 2020–01 Amendment 1:2022–05 Biological evaluation of medical devices—Part 18: Chemical characterization
of medical device materials within a risk management process [Including Amendment 1 (2022)].
ISO 10993–12 Fifth edition 2021–01 Biological evaluation of medical devices—Part 12: Sample preparation and reference materials.
ISO 10993–10 Fourth edition 2021–11 Biological evaluation of medical
devices—Part 10: Tests for skin sensitization.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version, including amendment.
Transition period extended.
Transition period extended.
C. Cardiovascular
No new entries at this time.
D. Dental/Ear, Nose, and Throat
4–234 .........
4–294
ANSI/ADA Standard No. 139–2020 Dental Base Polymers .......................
Withdrawn and replaced with newer
version.
ddrumheller on DSK120RN23PROD with NOTICES1
E. General I (Quality Systems/Risk Management) (QS/RM)
15–135 .......
5–135
5–99 ...........
5–136
5–104 .........
5–137
5–118 .........
5–138
5–119 .........
5–139
ISO 20417 First edition 2021–04 Corrected version 2021–12 Medical devices—Information to be supplied by the manufacturer.
ASTM D4332–22 Standard Practice for Conditioning Containers, Packages, or Packaging Components for Testing.
IEC TR 60878 Edition 4.0 2022–11 Graphical symbols for electrical
equipment in medical practice.
AAMI TIR66:2017/(R)2020 Guidance for the creation of physiologic data
and waveform databases to demonstrate reasonable assurance of the
safety and effectiveness of alarm system algorithms.
ISO 18250–3 First edition 2018–06 Medical devices—Connectors for reservoir delivery systems for healthcare applications—Part 3: Enteral application.
New recognition number.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
New recognition number.
New recognition number.
F. General II (Electrical Safety/Electromagnetic Compatibility) (ES/EMC)
19–29 .........
VerDate Sep<11>2014
19–48
19:49 Aug 01, 2023
IEEE ANSI/USEMCSC C63.27 American National Standard for Evaluation of Wireless Coexistence.
Jkt 259001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
E:\FR\FM\02AUN1.SGM
Withdrawn and replaced with newer
version.
02AUN1
50873
Federal Register / Vol. 88, No. 147 / Wednesday, August 2, 2023 / Notices
TABLE 1—MODIFICATIONS TO THE LIST OF RECOGNIZED STANDARDS—Continued
Old
recognition
No.
Replacement
recognition
No.
Title of standard 1
Change
G. General Hospital/General Plastic Surgery (GH/GPS)
6–390 .........
........................
6–460 .........
6–484
IEC 80601–2–35 Edition 2.1 2016–04 CONSOLIDATED VERSION Medical electrical equipment-Part—2–35: Particular requirements for the
basic safety and essential performance of heating devices using blankets, pads or mattresses and intended for heating in medical use [Including Amendment 1 (2016)].
ASTM F3502–22a Standard Specification for Barrier Face Coverings ......
Withdrawn. See 6–483.
Extent of recognition. Withdrawn and
replaced with a newer version.
H. In Vitro Diagnostics (IVD)
7–291 .........
7–313
7–303 .........
........................
CLSI EP27 2nd Edition Constructing and Interpreting an Error Grid for
Quantitative Measurement Procedures.
CLSI M60 2nd Edition Performance Standards for Antifungal Susceptibility Testing of Yeast.
Extent of recognition. Withdrawn and
replaced with newer version.
Withdrawn. See 7–314.
I. Materials
8–61 ...........
8–594
8–123 .........
8–595
8–559 .........
8–596
ISO 5832–6 Third Edition 2022–03 Implants for surgery—Metallic materials—Part 6: Wrought cobalt-nickel-chromium-molybdenum alloy.
ISO 5832–5 Fourth Edition 2022–03 Implants for surgery—Metallic materials—Part 5: Wrought cobalt-chromium-tungsten-nickel.
ASTM D412–16(2021) Standard Test Methods for Vulcanized Rubber
and Thermoplastic Elastomers—Tension.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
J. Nanotechnology
18–4 ...........
18–21
18–12 .........
18–22
ISO/TS 80004–6 Second edition 2021–03 Nanotechnologies—Vocabulary—Part 6: Nano-object characterization.
ISO 17200 First edition 2020–09 Nanotechnology—Nanoparticles in powder form—Characteristics and measurements.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
K. Neurology
No new entries at this time.
L. Obstetrics-Gynecology/Gastroenterology/Urology (OB-Gyn/G/Urology)
9–89 ...........
........................
ISO 8638 Third edition 2010–07–01 Cardiovascular implants and
extracorporeal systems—Extracorporeal blood circuit for
hemodialyzers, hemodialfilters, and hemofilters.
Withdrawn. See 9–140.
M. Ophthalmic
10–37 .........
10–132
10–91 .........
10–133
ISO 10942 Third edition 2022–01 Ophthalmic instruments—Direct
ophthalmoscopes.
ISO 11979–10 Second edition 2018–03 Ophthalmic implants—Intraocular
lenses—Part 10: Clinical investigations of intraocular lenses for correction of ametropia in phakic eyes.
Extent of recognition. Withdrawn and
replaced with newer version.
Withdrawn and replaced with newer
version.
ddrumheller on DSK120RN23PROD with NOTICES1
N. Orthopedic
11–264 .......
11–394
11–306 .......
11–395
11–320 .......
11–396
ASTM F1820–22 Standard Test Method for Determining the Forces for
Disassembly of Modular Acetabular Devices.
ASTM F1814–22 Standard Guide for Evaluating Modular Hip and Knee
Joint Components.
ISO 7206–13 First edition 2016–07–01 [Including AMD1:2022] Implants
for surgery—Partial and total hip joint prostheses—Part 13: Determination of resistance to torque of head fixation of stemmed femoral components [Including Amendment 1 (2022)].
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version including amendment.
O. Physical Medicine
16–191 .......
........................
ISO 7176–16 Second edition 2012–12–01 Wheelchairs—Part 16: Resistance to ignition of postural support devices.
Withdrawn. See 16–233.
P. Radiology
12–113 .......
VerDate Sep<11>2014
12–346
19:49 Aug 01, 2023
ISO 12005 Third edition 2022–05 Lasers and laser-related equipment—
Test methods for laser beam parameters—Polarization.
Jkt 259001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
E:\FR\FM\02AUN1.SGM
Withdrawn and replaced with newer
version.
02AUN1
50874
Federal Register / Vol. 88, No. 147 / Wednesday, August 2, 2023 / Notices
TABLE 1—MODIFICATIONS TO THE LIST OF RECOGNIZED STANDARDS—Continued
Old
recognition
No.
Replacement
recognition
No.
12–295 .......
12–347
12–317 .......
12–348
12–342 .......
12–349
Title of standard 1
Change
IEC 60601–2–33 Edition 4.0 2022–08 Medical electrical equipment—Part
2–33: Particular requirements for the basic safety and essential performance of magnetic resonance equipment for medical diagnosis.
IEC 60601–2–54 Edition 2.0 2022–09 Medical electrical equipment—Part
2–54: Particular requirements for the basic safety and essential performance of X-ray equipment for radiography and radioscopy.
NEMA Digital Imaging and Communications in Medicine (DICOM) Set
PS3.1–3.20 2022d.
Extent of recognition. Withdrawn and
replaced with newer version.
Extent of recognition. Withdrawn and
replaced with newer version.
Withdrawn and replaced with newer
version.
Q. Software/Informatics
13–109 .......
13–121
ANSI/AAMI/UL 2800–1:2022 Standard for Medical Device Interoperability
Withdrawn and replaced with newer
version. See 13–125, 13–126, 13–
127.
R. Sterility
14–409 .......
14–580
14–527 .......
14–581
ISO 11137–2 Third edition 2013–06 [Including AMD1:2022] Sterilization
of health care products—Radiation—Part 2: Establishing the sterilization dose [Including Amendment 1 (2022)].
ASTM F2638–22 Standard Test Method for Using Aerosol Filtration for
Measuring the Performance of Porous Packaging Materials as a Surrogate Microbial Barrier.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
S. Tissue Engineering
No new entries at this time.
1 All
standard titles in this table conform to the style requirements of the respective organizations.
III. Listing of New Entries
In table 2, FDA provides the listing of
new entries and consensus standards
added as modifications to the list of
recognized standards under Recognition
List Number: 059. These entries are of
standards not previously recognized by
FDA.
TABLE 2—NEW ENTRIES TO THE LIST OF RECOGNIZED STANDARDS
Recognition
No.
Title of standard 1
Reference No. and date
A. Anesthesiology
1–158 .........
1–159 .........
1–160 .........
Medical suction equipment—Part 4: General requirements ...........................................
Respiratory equipment—Particular requirements for basic safety and essential performance of infant cardiorespiratory monitors.
Medical electrical equipment—Part 2–84: Particular requirements for the basic safety
and essential performance of ventilators for the emergency medical services environment.
ISO 10079–4 First edition 2021–08.
ISO 18778 Second edition 2022–06.
ISO 80601–2–84 First edition 2020–07.
B. Biocompatibility
No new entries at this time.
C. Cardiovascular
3–183 .........
Cardiovascular implants and extracorporeal systems—Blood/tissue contact surface
modifications for extracorporeal perfusion systems.
ISO 11658 First edition 2012–05–15.
ddrumheller on DSK120RN23PROD with NOTICES1
D. Dental/ENT
4–295 .........
4–296 .........
4–297 .........
Evaluation of biocompatibility of medical devices used in dentistry ..............................
Dentistry—Intra-oral mirrors ............................................................................................
Dentistry—Manual toothbrushes—General requirements and test methods .................
ANSI/ADA Standard No. 41–2020.
ISO 9873 Fourth edition 2019–03.
ISO 20126 Third edition 2022–03.
E. General I (QS/RM)
5–140 .........
5–141 .........
VerDate Sep<11>2014
Standard for verification and validation in computational solid mechanics ....................
Standard for verification and validation in computational fluid dynamics and heat
transfer.
19:49 Aug 01, 2023
Jkt 259001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
ASME V&V 10–2019.
ASME V&V 20–2009 (R2021).
E:\FR\FM\02AUN1.SGM
02AUN1
Federal Register / Vol. 88, No. 147 / Wednesday, August 2, 2023 / Notices
50875
TABLE 2—NEW ENTRIES TO THE LIST OF RECOGNIZED STANDARDS—Continued
Recognition
No.
Title of standard 1
Reference No. and date
F. General II (ES/EMC)
No new entries at this time.
G. GH/GPS
6–483 .........
6–485 .........
Medical electrical equipment—Part 2–35: Particular requirements for the basic safety
and essential performance of heating devices using blankets, pads and mattresses
and intended for heating in medical use.
Sterile hypodermic syringes for single use—Part 4: Syringes with re-use prevention
feature.
IEC 60601–2–35 Edition 2.0 2020–09.
ISO 7886–4 Second Edition 2018–11.
H. IVD
7–314 .........
Performance Standards for Antifungal Susceptibility Testing of Yeasts ........................
CLSI M27M44S, 3rd Edition.
I. Materials
No new entries at this time.
J. Nanotechnology
No new entries at this time.
K. Neurology
No new entries at this time.
L. OB-Gyn/G/Urology
9–140 .........
9–143 .........
Extracorporeal systems for blood purification—Part 2: Extracorporeal blood circuit for
hemodialyzers, hemodiafilters and hemofilters.
Extracorporeal systems for blood purification—Part 3: Plasmafilters ............................
Standard test method for static and kinetic coefficients of friction of plastic film and
sheeting.
Sterile urethral catheters for single use ..........................................................................
9–144 .........
Sterile drainage catheters and accessory devices for single use ..................................
9–141 .........
9–142 .........
ISO 8637–2 First Edition 2018–07.
ISO 8637–3 First Edition 2018–07.
ASTM D1894–14.
ISO 20696 First edition 2018–06 Corrected 2019–12.
ISO 20697 First edition 2018–06 Corrected 2019–09.
M. Ophthalmic
No new entries at this time.
N. Orthopedic
11–397 .......
11–398 .......
Standard test method for fatigue testing of total knee femoral components under
closing conditions.
Standard test methods for sacroiliac joint fusion devices ..............................................
ASTM F3210–22e1.
ASTM F3574–22.
O. Physical Medicine
16–233 .......
Wheelchair seating—Part 10: Resistance to ignition of postural support devices—Requirements and test method.
ISO 16840–10 Second edition 2021–06
Corrected version 2022–01.
P. Radiology
No new entries at this time.
Q. Software/Informatics
ddrumheller on DSK120RN23PROD with NOTICES1
13–122 .......
13–123 .......
13–124 .......
13–125
13–126
13–127
13–128
.......
.......
.......
.......
VerDate Sep<11>2014
Health software and health IT systems safety, effectiveness and security—Part 5–1:
Security—Activities in the product life cycle.
Manufacturer disclosure statement for medical device security ....................................
Guidance on the application of ISO 14971 to artificial intelligence and machine learning.
Standard for risk concerns for interoperable medical products .....................................
Standard for interoperable item development life cycle .................................................
Standard for Interoperable item integration life cycle .....................................................
IEEE/UL Standard for wireless diabetes device security: Information security requirements for connected diabetes solutions.
19:49 Aug 01, 2023
Jkt 259001
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
IEC 81001–5–1 Edition 1.0 2021–12.
ANSI/NEMA HN 1–2019.
AAMI CR34971:2022.
ANSI/AAMI/UL 2800–1–1:2022.
ANSI/AAMI/UL 2800–1–2:2022.
ANSI/AAMI/UL 2800–1–3:2022.
IEEE Std 2621.2–2022/UL 2621–2:2022.
E:\FR\FM\02AUN1.SGM
02AUN1
50876
Federal Register / Vol. 88, No. 147 / Wednesday, August 2, 2023 / Notices
TABLE 2—NEW ENTRIES TO THE LIST OF RECOGNIZED STANDARDS—Continued
Recognition
No.
Title of standard 1
Reference No. and date
R. Sterility
14–582 .......
14–583 .......
Sterilization of health care products—Radiation—Part 4: Guidance on process control
Cleaning validation of health care products—Requirements for development and validation of a cleaning process for medical devices..
ISO/TS 11137–4 First edition 2020–06.
ANSI/AAMI ST98:2022.
S. Tissue Engineering
No new entries at this time.
1 All
standard titles in this table conform to the style requirements of the respective organizations.
IV. List of Recognized Standards
FDA maintains the current list of FDA
Recognized Consensus Standards in a
searchable database that may be
accessed at https://
www.accessdata.fda.gov/scripts/cdrh/
cfdocs/cfStandards/search.cfm. Such
standards are those that FDA has
recognized by notice published in the
Federal Register or that FDA has
decided to recognize but for which
recognition is pending (because a
periodic notice has not yet appeared in
the Federal Register). FDA will
announce additional modifications and
revisions to the list of recognized
consensus standards, as needed, in the
Federal Register once a year, or more
often if necessary.
V. Recommendation of Standards for
Recognition by FDA
Any person may recommend
consensus standards as candidates for
recognition under section 514 of the
FD&C Act by submitting such
recommendations, with reasons for the
recommendation, to
CDRHStandardsStaff@fda.hhs.gov. To
be considered, such recommendations
should contain, at a minimum, the
information available at https://
www.fda.gov/medical-devices/deviceadvice-comprehensive-regulatoryassistance/standards-and-conformityassessment-program#process.
Dated: July 28, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
ddrumheller on DSK120RN23PROD with NOTICES1
[FR Doc. 2023–16418 Filed 8–1–23; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014
19:49 Aug 01, 2023
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2023–N–2780]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Premarket
Notification for a New Dietary
Ingredient
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the procedure by
which a manufacturer or distributor of
a new dietary ingredient or of a dietary
supplement containing a new dietary
ingredient is to submit to FDA
information upon which it has based its
conclusion that a dietary supplement
containing the new dietary ingredient
will reasonably be expected to be safe.
DATES: Either electronic or written
comments on the collection of
information must be submitted by
October 2, 2023.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. The https://
www.regulations.gov electronic filing
system will accept comments until
11:59 p.m. Eastern Time at the end of
October 2, 2023. Comments received by
mail/hand delivery/courier (for written/
paper submissions) will be considered
timely if they are received on or before
that date.
SUMMARY:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2023–N–2780 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request;
Premarket Notification for a New
E:\FR\FM\02AUN1.SGM
02AUN1
Agencies
[Federal Register Volume 88, Number 147 (Wednesday, August 2, 2023)]
[Notices]
[Pages 50870-50876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-16418]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2004-N-0451]
Food and Drug Administration Modernization Act of 1997:
Modifications to the List of Recognized Standards, Recognition List
Number: 059
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
a publication containing modifications the Agency is making to the list
of standards FDA recognizes for use in premarket reviews (FDA
Recognized Consensus Standards). This publication, entitled
``Modifications to the List of Recognized Standards, Recognition List
Number: 059'' (Recognition List Number: 059), will assist manufacturers
who elect to declare conformity with consensus standards to meet
certain requirements for medical devices.
[[Page 50871]]
DATES: Submit either electronic or written comments on the notice at
any time. These modifications to the list of recognized standards are
applicable August 2, 2023.
ADDRESSES: You may submit comments on the current list of FDA
Recognized Consensus Standards at any time as follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2004-N-0451 for ``Food and Drug Administration Modernization Act of
1997: Modifications to the List of Recognized Standards, Recognition
List Number: 059.'' Received comments will be placed in the docket and,
except for those submitted as ``Confidential Submissions,'' publicly
viewable at https://www.regulations.gov or at the Dockets Management
Staff between 9 a.m. and 4 p.m., Monday through Friday, 240-402-7500.
FDA will consider any comments received in determining whether to amend
the current listing of modifications to the list of recognized
standards, Recognition List Number: 059.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
An electronic copy of Recognition List Number: 059 is available on
the internet at https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Standards/ucm123792.htm. See section IV for
electronic access to the searchable database for the current list of
FDA-recognized consensus standards, including Recognition List Number:
059 modifications and other standards-related information. Submit
written requests for a single hard copy of the document entitled
``Modifications to the List of Recognized Standards, Recognition List
Number: 059'' to Jianchao Zeng, Center for Devices and Radiological
Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg.
66, Rm. 5572, Silver Spring, MD 20993, 301-796-6580. Send one self-
addressed adhesive label to assist that office in processing your
request, or fax your request to 301-847-8144.
FOR FURTHER INFORMATION CONTACT: Jianchao Zeng, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5572, Silver Spring, MD 20993, 301-796-6580,
[email protected].
SUPPLEMENTARY INFORMATION:
I. Background
Section 204 of the Food and Drug Administration Modernization Act
of 1997 (Pub. L. 105-115) amended section 514 of the Federal Food,
Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 360d). Amended section 514
of the FD&C Act allows FDA to recognize consensus standards developed
by international and national organizations for use in satisfying
portions of device premarket review submissions or other requirements.
In the Federal Register of September 14, 2018 (83 FR 46738), FDA
announced the availability of a guidance entitled ``Appropriate Use of
Voluntary Consensus Standards in Premarket Submissions for Medical
Devices.'' The guidance describes how FDA has implemented its standards
recognition program and is available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/appropriate-use-voluntary-consensus-standards-premarket-submissions-medical-devices.
Modifications to the initial list of recognized standards, as published
in the Federal Register, can be accessed at https://www.fda.gov/medical-devices/standards-and-conformity-assessment-program/federal-register-documents.
These notices describe the addition, withdrawal, and revision of
certain standards recognized by FDA. The Agency maintains on its
website HTML and PDF versions of the list of FDA Recognized Consensus
Standards, available at https://www.fda.gov/medical-devices/standards-and-conformity-assessment-program/federal-register-documents.
Additional information on the Agency's Standards and Conformity
Assessment Program is available at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/standards-and-conformity-assessment-program.
[[Page 50872]]
II. Modifications to the List of Recognized Standards, Recognition List
Number: 059
FDA is announcing the addition, withdrawal, correction, and
revision of certain consensus standards the Agency is recognizing for
use in premarket submissions and other requirements for devices. FDA is
incorporating these modifications to the list of FDA Recognized
Consensus Standards in the Agency's searchable database. FDA is using
the term ``Recognition List Number: 059'' to identify the current
modifications.
In table 1, FDA describes the following modifications: (1) the
withdrawal of standards and their replacement by others, if applicable;
(2) the correction of errors made by FDA in listing previously
recognized standards; and (3) the changes to the supplementary
information sheets of recognized standards that describe revisions to
the applicability of the standards.
In section III, FDA lists modifications the Agency is making that
involve new entries and consensus standards added as modifications to
the list of recognized standards under Recognition List Number: 059.
Table 1--Modifications to the List of Recognized Standards
------------------------------------------------------------------------
Replacement
Old recognition recognition Title of standard \1\ Change
No. No.
------------------------------------------------------------------------
A. Anesthesiology
------------------------------------------------------------------------
1-67........... 1-153 NFPA 99:2021 Health Withdrawn and
Care Facilities Code. replaced with
newer version.
1-78........... 1-154 ASME PVHO-1-2019 Withdrawn and
Safety Standard for replaced with
Pressure Vessels for newer version.
Human Occupancy.
1-132.......... 1-155 ISO 10079-2 Fourth Withdrawn and
edition 2022-03 replaced with
Medical suction newer version.
equipment--Part 2:
Manually powered
suction equipment.
1-133.......... 1-156 ISO 10079-3 Fourth Withdrawn and
edition 2022-03 replaced with
Medical suction newer version.
equipment--Part 3:
Suction equipment
powered from a
vacuum or positive
pressure gas source.
1-142.......... 1-157 ISO 10079-1 Fourth Withdrawn and
edition 2022-03 replaced with
Medical suction newer version.
equipment--Part 1:
Electrically powered
suction equipment.
------------------------------------------------------------------------
B. Biocompatibility
------------------------------------------------------------------------
2-93........... 2-297 ASTM F763-22 Standard Withdrawn and
Practice for Short- replaced with
Term Intramuscular newer version.
Screening of
Implantable Medical
Device Materials.
2-276.......... 2-298 ISO 10993-18 Second Withdrawn and
edition 2020-01 replaced with
Amendment 1:2022-05 newer version,
Biological including
evaluation of amendment.
medical devices--
Part 18: Chemical
characterization of
medical device
materials within a
risk management
process [Including
Amendment 1 (2022)].
2-289.......... .............. ISO 10993-12 Fifth Transition
edition 2021-01 period
Biological extended.
evaluation of
medical devices--
Part 12: Sample
preparation and
reference materials.
2-296.......... .............. ISO 10993-10 Fourth Transition
edition 2021-11 period
Biological extended.
evaluation of
medical devices--
Part 10: Tests for
skin sensitization.
------------------------------------------------------------------------
C. Cardiovascular
------------------------------------------------------------------------
No new entries at this time.
------------------------------------------------------------------------
D. Dental/Ear, Nose, and Throat
------------------------------------------------------------------------
4-234.......... 4-294 ANSI/ADA Standard No. Withdrawn and
139-2020 Dental Base replaced with
Polymers. newer version.
------------------------------------------------------------------------
E. General I (Quality Systems/Risk Management) (QS/RM)
------------------------------------------------------------------------
15-135......... 5-135 ISO 20417 First New recognition
edition 2021-04 number.
Corrected version
2021-12 Medical
devices--Information
to be supplied by
the manufacturer.
5-99........... 5-136 ASTM D4332-22 Withdrawn and
Standard Practice replaced with
for Conditioning newer version.
Containers,
Packages, or
Packaging Components
for Testing.
5-104.......... 5-137 IEC TR 60878 Edition Withdrawn and
4.0 2022-11 replaced with
Graphical symbols newer version.
for electrical
equipment in medical
practice.
5-118.......... 5-138 AAMI TIR66:2017/ New recognition
(R)2020 Guidance for number.
the creation of
physiologic data and
waveform databases
to demonstrate
reasonable assurance
of the safety and
effectiveness of
alarm system
algorithms.
5-119.......... 5-139 ISO 18250-3 First New recognition
edition 2018-06 number.
Medical devices--
Connectors for
reservoir delivery
systems for
healthcare
applications--Part
3: Enteral
application.
------------------------------------------------------------------------
F. General II (Electrical Safety/Electromagnetic Compatibility) (ES/EMC)
------------------------------------------------------------------------
19-29.......... 19-48 IEEE ANSI/USEMCSC Withdrawn and
C63.27 American replaced with
National Standard newer version.
for Evaluation of
Wireless Coexistence.
------------------------------------------------------------------------
[[Page 50873]]
G. General Hospital/General Plastic Surgery (GH/GPS)
------------------------------------------------------------------------
6-390.......... .............. IEC 80601-2-35 Withdrawn. See 6-
Edition 2.1 2016-04 483.
CONSOLIDATED VERSION
Medical electrical
equipment-Part--2-
35: Particular
requirements for the
basic safety and
essential
performance of
heating devices
using blankets, pads
or mattresses and
intended for heating
in medical use
[Including Amendment
1 (2016)].
6-460.......... 6-484 ASTM F3502-22a Extent of
Standard recognition.
Specification for Withdrawn and
Barrier Face replaced with a
Coverings. newer version.
------------------------------------------------------------------------
H. In Vitro Diagnostics (IVD)
------------------------------------------------------------------------
7-291.......... 7-313 CLSI EP27 2nd Edition Extent of
Constructing and recognition.
Interpreting an Withdrawn and
Error Grid for replaced with
Quantitative newer version.
Measurement
Procedures.
7-303.......... .............. CLSI M60 2nd Edition Withdrawn. See 7-
Performance 314.
Standards for
Antifungal
Susceptibility
Testing of Yeast.
------------------------------------------------------------------------
I. Materials
------------------------------------------------------------------------
8-61........... 8-594 ISO 5832-6 Third Withdrawn and
Edition 2022-03 replaced with
Implants for newer version.
surgery--Metallic
materials--Part 6:
Wrought cobalt-
nickel-chromium-
molybdenum alloy.
8-123.......... 8-595 ISO 5832-5 Fourth Withdrawn and
Edition 2022-03 replaced with
Implants for newer version.
surgery--Metallic
materials--Part 5:
Wrought cobalt-
chromium-tungsten-
nickel.
8-559.......... 8-596 ASTM D412-16(2021) Withdrawn and
Standard Test replaced with
Methods for newer version.
Vulcanized Rubber
and Thermoplastic
Elastomers--Tension.
------------------------------------------------------------------------
J. Nanotechnology
------------------------------------------------------------------------
18-4........... 18-21 ISO/TS 80004-6 Second Withdrawn and
edition 2021-03 replaced with
Nanotechnologies--Vo newer version.
cabulary--Part 6:
Nano-object
characterization.
18-12.......... 18-22 ISO 17200 First Withdrawn and
edition 2020-09 replaced with
Nanotechnology--Nano newer version.
particles in powder
form--Characteristic
s and measurements.
------------------------------------------------------------------------
K. Neurology
------------------------------------------------------------------------
No new entries at this time.
------------------------------------------------------------------------
L. Obstetrics-Gynecology/Gastroenterology/Urology (OB-Gyn/G/Urology)
------------------------------------------------------------------------
9-89........... .............. ISO 8638 Third Withdrawn. See 9-
edition 2010-07-01 140.
Cardiovascular
implants and
extracorporeal
systems--Extracorpor
eal blood circuit
for hemodialyzers,
hemodialfilters, and
hemofilters.
------------------------------------------------------------------------
M. Ophthalmic
------------------------------------------------------------------------
10-37.......... 10-132 ISO 10942 Third Extent of
edition 2022-01 recognition.
Ophthalmic Withdrawn and
instruments--Direct replaced with
ophthalmoscopes. newer version.
10-91.......... 10-133 ISO 11979-10 Second Withdrawn and
edition 2018-03 replaced with
Ophthalmic implants-- newer version.
Intraocular lenses--
Part 10: Clinical
investigations of
intraocular lenses
for correction of
ametropia in phakic
eyes.
------------------------------------------------------------------------
N. Orthopedic
------------------------------------------------------------------------
11-264......... 11-394 ASTM F1820-22 Withdrawn and
Standard Test Method replaced with
for Determining the newer version.
Forces for
Disassembly of
Modular Acetabular
Devices.
11-306......... 11-395 ASTM F1814-22 Withdrawn and
Standard Guide for replaced with
Evaluating Modular newer version.
Hip and Knee Joint
Components.
11-320......... 11-396 ISO 7206-13 First Withdrawn and
edition 2016-07-01 replaced with
[Including newer version
AMD1:2022] Implants including
for surgery--Partial amendment.
and total hip joint
prostheses--Part 13:
Determination of
resistance to torque
of head fixation of
stemmed femoral
components
[Including Amendment
1 (2022)].
------------------------------------------------------------------------
O. Physical Medicine
------------------------------------------------------------------------
16-191......... .............. ISO 7176-16 Second Withdrawn. See
edition 2012-12-01 16-233.
Wheelchairs--Part
16: Resistance to
ignition of postural
support devices.
------------------------------------------------------------------------
P. Radiology
------------------------------------------------------------------------
12-113......... 12-346 ISO 12005 Third Withdrawn and
edition 2022-05 replaced with
Lasers and laser- newer version.
related equipment--
Test methods for
laser beam
parameters--Polariza
tion.
[[Page 50874]]
12-295......... 12-347 IEC 60601-2-33 Extent of
Edition 4.0 2022-08 recognition.
Medical electrical Withdrawn and
equipment--Part 2- replaced with
33: Particular newer version.
requirements for the
basic safety and
essential
performance of
magnetic resonance
equipment for
medical diagnosis.
12-317......... 12-348 IEC 60601-2-54 Extent of
Edition 2.0 2022-09 recognition.
Medical electrical Withdrawn and
equipment--Part 2- replaced with
54: Particular newer version.
requirements for the
basic safety and
essential
performance of X-ray
equipment for
radiography and
radioscopy.
12-342......... 12-349 NEMA Digital Imaging Withdrawn and
and Communications replaced with
in Medicine (DICOM) newer version.
Set PS3.1-3.20 2022d.
------------------------------------------------------------------------
Q. Software/Informatics
------------------------------------------------------------------------
13-109......... 13-121 ANSI/AAMI/UL 2800- Withdrawn and
1:2022 Standard for replaced with
Medical Device newer version.
Interoperability. See 13-125, 13-
126, 13-127.
------------------------------------------------------------------------
R. Sterility
------------------------------------------------------------------------
14-409......... 14-580 ISO 11137-2 Third Withdrawn and
edition 2013-06 replaced with
[Including newer version.
AMD1:2022]
Sterilization of
health care
products--Radiation-
-Part 2:
Establishing the
sterilization dose
[Including Amendment
1 (2022)].
14-527......... 14-581 ASTM F2638-22 Withdrawn and
Standard Test Method replaced with
for Using Aerosol newer version.
Filtration for
Measuring the
Performance of
Porous Packaging
Materials as a
Surrogate Microbial
Barrier.
------------------------------------------------------------------------
S. Tissue Engineering
------------------------------------------------------------------------
No new entries at this time.
------------------------------------------------------------------------
\1\ All standard titles in this table conform to the style requirements
of the respective organizations.
III. Listing of New Entries
In table 2, FDA provides the listing of new entries and consensus
standards added as modifications to the list of recognized standards
under Recognition List Number: 059. These entries are of standards not
previously recognized by FDA.
Table 2--New Entries to the List of Recognized Standards
------------------------------------------------------------------------
Reference No. and
Recognition No. Title of standard \1\ date
------------------------------------------------------------------------
A. Anesthesiology
------------------------------------------------------------------------
1-158................ Medical suction equipment-- ISO 10079-4 First
Part 4: General edition 2021-08.
requirements.
1-159................ Respiratory equipment-- ISO 18778 Second
Particular requirements edition 2022-06.
for basic safety and
essential performance of
infant cardiorespiratory
monitors.
1-160................ Medical electrical ISO 80601-2-84 First
equipment--Part 2-84: edition 2020-07.
Particular requirements
for the basic safety and
essential performance of
ventilators for the
emergency medical
services environment.
------------------------------------------------------------------------
B. Biocompatibility
------------------------------------------------------------------------
No new entries at this time.
------------------------------------------------------------------------
C. Cardiovascular
------------------------------------------------------------------------
3-183................ Cardiovascular implants ISO 11658 First
and extracorporeal edition 2012-05-15.
systems--Blood/tissue
contact surface
modifications for
extracorporeal perfusion
systems.
------------------------------------------------------------------------
D. Dental/ENT
------------------------------------------------------------------------
4-295................ Evaluation of ANSI/ADA Standard No.
biocompatibility of 41-2020.
medical devices used in
dentistry.
4-296................ Dentistry--Intra-oral ISO 9873 Fourth
mirrors. edition 2019-03.
4-297................ Dentistry--Manual ISO 20126 Third
toothbrushes--General edition 2022-03.
requirements and test
methods.
------------------------------------------------------------------------
E. General I (QS/RM)
------------------------------------------------------------------------
5-140................ Standard for verification ASME V&V 10-2019.
and validation in
computational solid
mechanics.
5-141................ Standard for verification ASME V&V 20-2009
and validation in (R2021).
computational fluid
dynamics and heat
transfer.
------------------------------------------------------------------------
[[Page 50875]]
F. General II (ES/EMC)
------------------------------------------------------------------------
No new entries at this time.
------------------------------------------------------------------------
G. GH/GPS
------------------------------------------------------------------------
6-483................ Medical electrical IEC 60601-2-35
equipment--Part 2-35: Edition 2.0 2020-09.
Particular requirements
for the basic safety and
essential performance of
heating devices using
blankets, pads and
mattresses and intended
for heating in medical
use.
6-485................ Sterile hypodermic ISO 7886-4 Second
syringes for single use-- Edition 2018-11.
Part 4: Syringes with re-
use prevention feature.
------------------------------------------------------------------------
H. IVD
------------------------------------------------------------------------
7-314................ Performance Standards for CLSI M27M44S, 3rd
Antifungal Susceptibility Edition.
Testing of Yeasts.
------------------------------------------------------------------------
I. Materials
------------------------------------------------------------------------
No new entries at this time.
------------------------------------------------------------------------
J. Nanotechnology
------------------------------------------------------------------------
No new entries at this time.
------------------------------------------------------------------------
K. Neurology
------------------------------------------------------------------------
No new entries at this time.
------------------------------------------------------------------------
L. OB-Gyn/G/Urology
------------------------------------------------------------------------
9-140................ Extracorporeal systems for ISO 8637-2 First
blood purification--Part Edition 2018-07.
2: Extracorporeal blood
circuit for
hemodialyzers,
hemodiafilters and
hemofilters.
9-141................ Extracorporeal systems for ISO 8637-3 First
blood purification--Part Edition 2018-07.
3: Plasmafilters.
9-142................ Standard test method for ASTM D1894-14.
static and kinetic
coefficients of friction
of plastic film and
sheeting.
9-143................ Sterile urethral catheters ISO 20696 First
for single use. edition 2018-06
Corrected 2019-12.
9-144................ Sterile drainage catheters ISO 20697 First
and accessory devices for edition 2018-06
single use. Corrected 2019-09.
------------------------------------------------------------------------
M. Ophthalmic
------------------------------------------------------------------------
No new entries at this time.
------------------------------------------------------------------------
N. Orthopedic
------------------------------------------------------------------------
11-397............... Standard test method for ASTM F3210-22e1.
fatigue testing of total
knee femoral components
under closing conditions.
11-398............... Standard test methods for ASTM F3574-22.
sacroiliac joint fusion
devices.
------------------------------------------------------------------------
O. Physical Medicine
------------------------------------------------------------------------
16-233............... Wheelchair seating--Part ISO 16840-10 Second
10: Resistance to edition 2021-06
ignition of postural Corrected version
support devices-- 2022-01.
Requirements and test
method.
------------------------------------------------------------------------
P. Radiology
------------------------------------------------------------------------
No new entries at this time.
------------------------------------------------------------------------
Q. Software/Informatics
------------------------------------------------------------------------
13-122............... Health software and health IEC 81001-5-1 Edition
IT systems safety, 1.0 2021-12.
effectiveness and
security--Part 5-1:
Security--Activities in
the product life cycle.
13-123............... Manufacturer disclosure ANSI/NEMA HN 1-2019.
statement for medical
device security.
13-124............... Guidance on the AAMI CR34971:2022.
application of ISO 14971
to artificial
intelligence and machine
learning.
13-125............... Standard for risk concerns ANSI/AAMI/UL 2800-1-
for interoperable medical 1:2022.
products.
13-126............... Standard for interoperable ANSI/AAMI/UL 2800-1-
item development life 2:2022.
cycle.
13-127............... Standard for Interoperable ANSI/AAMI/UL 2800-1-
item integration life 3:2022.
cycle.
13-128............... IEEE/UL Standard for IEEE Std 2621.2-2022/
wireless diabetes device UL 2621-2:2022.
security: Information
security requirements for
connected diabetes
solutions.
------------------------------------------------------------------------
[[Page 50876]]
R. Sterility
------------------------------------------------------------------------
14-582............... Sterilization of health ISO/TS 11137-4 First
care products--Radiation-- edition 2020-06.
Part 4: Guidance on
process control.
14-583............... Cleaning validation of ANSI/AAMI ST98:2022.
health care products--
Requirements for
development and
validation of a cleaning
process for medical
devices..
------------------------------------------------------------------------
S. Tissue Engineering
------------------------------------------------------------------------
No new entries at this time.
------------------------------------------------------------------------
\1\ All standard titles in this table conform to the style requirements
of the respective organizations.
IV. List of Recognized Standards
FDA maintains the current list of FDA Recognized Consensus
Standards in a searchable database that may be accessed at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/search.cfm. Such
standards are those that FDA has recognized by notice published in the
Federal Register or that FDA has decided to recognize but for which
recognition is pending (because a periodic notice has not yet appeared
in the Federal Register). FDA will announce additional modifications
and revisions to the list of recognized consensus standards, as needed,
in the Federal Register once a year, or more often if necessary.
V. Recommendation of Standards for Recognition by FDA
Any person may recommend consensus standards as candidates for
recognition under section 514 of the FD&C Act by submitting such
recommendations, with reasons for the recommendation, to
[email protected]. To be considered, such recommendations
should contain, at a minimum, the information available at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/standards-and-conformity-assessment-program#process.
Dated: July 28, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-16418 Filed 8-1-23; 8:45 am]
BILLING CODE 4164-01-P